0001607062-19-000359.txt : 20190911
0001607062-19-000359.hdr.sgml : 20190911
20190911154559
ACCESSION NUMBER: 0001607062-19-000359
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190627
FILED AS OF DATE: 20190911
DATE AS OF CHANGE: 20190911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prioletti Mark Joseph SE
CENTRAL INDEX KEY: 0001786759
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 191088252
MAIL ADDRESS:
STREET 1: 1121 PALMER COURT
CITY: CRYSTAL LAKE
STATE: IL
ZIP: 60014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 416-364-2551
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
3
1
ownership.xml
X0206
3
2019-06-27
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001786759
Prioletti Mark Joseph SE
1121 PALMER COURT
CRYSTAL LAKE
IL
60014
1
0
0
0
Common Voting Shares
3568
D
/s/ Mark Prioletti
2019-06-27